Arch Therapeutics, Inc.
Arch Therapeutics, Inc. (ARTH) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 20 transactions totaling $7.7K, demonstrating a bullish sentiment with $7.7K in net insider flow. The most recent transaction on Aug 31, 2023 involved a purchase of 10,292 shares valued at $2.9K.
ARTH Insider Activity Summary
Who Is Buying ARTH Stock?
No significant insider buying has been recorded for ARTH in the recent period.
Who Is Selling ARTH Stock?
No significant insider selling has been recorded for ARTH in the recent period.
Is Arch Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ARTH is bullish with an Insider Alignment Score of 100/100 and a net flow of $7.7K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ARTH Frequently Asked Questions
Understanding ARTH Insider Activity
Insider trading at Arch Therapeutics, Inc. (ARTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading ARTH stock, having executed 20 transactions in the past 90 days. The most active insider is James R. Sulat (Executive), who has made 5 transactions totaling $11.1K.
Related Tools
Track Arch Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ARTH file new Form 4 transactions